Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of epstein-barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma

Clinical Infectious Diseases

Volumn 38, Issue 11, 2004, Pages 1629-1632

  Ivers, Louise C ^a,b   Kim, Arthur Y ^b,c   Sax, Paul E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DNA DETERMINATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RELIABILITY; VIRUS DETECTION; VIRUS LOAD; VIRUS VIRULENCE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 2942627395     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/420934     Document Type: Article

References (18)

1. Antinori A, Ammassari A, Luzzati R, et al. Role of brain biopsy in the management of focal brain lesions in HIV-infected patients. Neurology 2000; 54:993-7.
2. Flinn IW, Ambinder RF. AIDS primary central nervous system lymphoma. Curr Opin Oncol 1996; 8:373-6.
3. Cinque P, Vago L, Dahl H, et al. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996; 10:951-8.
4. Al-Shahi R, Bower M, Nelson M, et al. Cerebrospinal fluid Epstein-Barr virus detection preceding HIV-associated primary central nervous system lymphoma by 17 months. J Neurol 2000; 247:471-2.
5. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary CNS lymphoma of the central nervous system. Lancet 1993; 342:398-401.
6. O'Malley JP, Ziessman HA, Kumar PN, Harkness BA, Tall JG, Pierce PF. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201Tl single-photon emission computed tomography. AJR Am J Roentgenol 1994; 163:417-21.
7. Lorberboym M, Estok L, Machac J, et al. Rapid differential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 1996; 37:1150-4.
8. D'Amico A, Messa C, Castagna A, et al. Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 1997; 18:741-50.
9. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectropscopy. Radiology 1995; 197:649-54.
10. Chang L, Miller B, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995; 197:525-31 (erratum: Radiology 1996; 198:586).
11. Cingolani A, Deluca A, Laroca LM, et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary nervous system lymphoma. J Natl Cancer Inst 1998; 90:346-7.
12. Roberts T, Storch G. Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. J Clin Microbiol 1997; 35:268-9.
13. Tachikawa N, Goto M, Hoshino Y, et al. Detection of Toxoplasma gondii, Epstein-Barr virus and JC virus DNAs in the cerebrospinal fluid in acquired immunodeficiency syndrome patients with focal central nervous system complications. Intern Med 1999; 38:556-62.
14. Antinori A, De Rossi G, Ammassari A, et al. Value of combined approach with thallium-201 single photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS related primary CNS lymphoma. J Clin Oncol 1999; 17:554-60.
15. Castagna A, Cinque P, D'Amico A, et al. Evaluation of contrast enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and thallium 201 single photon emission tomography. AIDS 1997; 11:1522-3.
16. Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related brain lesions: a decision making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 1997; 48:687-94.
17. Weinberg A, Li S, Palmer M, Tyler KL. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol 2002; 52:543-8.
18. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001; 37:1209-16.